News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kissei Pharmaceutical Co., Ltd. And Daiichi Pharmaceutical (JPN) Jointly Launch Urination Disorder Improving Drug


5/12/2006 1:25:21 PM

Tokyo, May 11, 2006 (JCN) - On May 10, Kissei Pharmaceutical and Daiichi Pharmaceutical jointly announced that they will launch URIEF Cap. 2mg/ 4mg (silodosin), an agent for treating urination disorder associated with benign prostatic hypertrophy (BPH), on May 11.

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES